Skip to main content

Larson Financial Group LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1731061 ST LOUIS, MO

Position in TGTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$248,817
+$35,259 QoQ
Shares Held
7,490
+4.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Dec 31, 2025
CallValue
$8,943
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Larson Financial Group LLC holds $4,055,906 across 194 Biotechnology names. TGTX ranks #3 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 TGTX
Tg Therapeutics, Inc.
This page
7,490 $248,817

All Filings in TGTX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $248,817 7,490
2025-12-31 $8,943 300
2025-12-31 $213,558 7,164
2025-09-30 $254,392 7,042
2025-09-30 $10,837 300
2025-06-30 $245,127 6,811
2025-03-31 $22,514 571
2024-12-31 $10,354 344